Trials / Completed
CompletedNCT05467475
A Study in Healthy Men to Test How Esomeprazole Influences the Amount of BI 1819479 in the Blood
The Effect of Multiple Doses of Esomeprazole on the Single-dose Pharmacokinetics of BI 1819479 Following Oral Administration in Healthy Male Subjects (an Open-label, Randomized, Two-way Cross-over Study)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The main objective of this trial is to investigate the effect of the proton pump inhibitor esomeprazole on the pharmacokinetics of BI 1819479 in plasma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BI 1819479 | BI 1819479 |
| DRUG | Esomeprazole | Esomeprazole |
Timeline
- Start date
- 2022-10-18
- Primary completion
- 2023-01-23
- Completion
- 2023-01-23
- First posted
- 2022-07-20
- Last updated
- 2023-01-26
Locations
1 site across 1 country: Germany
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05467475. Inclusion in this directory is not an endorsement.